Ductal Carcinoma In Situ of the Breast: Can Biomarkers Improve Current Management?

Detalles Bibliográficos
Publicado en:Clinical Chemistry Vol. 60; no. 1; pp. 60 - 68
Autores principales: Bartlett, John M. S., Nofech-Moses, Sharon, Rakovitch, Eileen
Formato: Journal Article
Publicado: Oxford University Press / USA Jan2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109663395&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 109663395
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00099147
        10CS
      jtl: Clinical Chemistry
      issn: 00099147
      maglogo: N
    pubinfo:
      dt: Jan2013
      vid: 60
      iid: 1
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        109663395
        2012433442
        10.1373/clinchem.2013.207183
        NLM24262106
        109663395
      ppf: 60
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Ductal Carcinoma In Situ of the Breast: Can Biomarkers Improve Current Management?
      aug:
        au:
          Bartlett, John M. S.
          Nofech-Moses, Sharon
          Rakovitch, Eileen
        affil: Ontario Institute for Cancer Research, Toronto, ON, Canada
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N